Article Information
History
- March 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- G Vilema-Enríquez1,
- R Quinlan2,3,
- P Kilfeather1,
- R Mazzone2,3,
- S Saqlain1,
- I del Molino del Barrio1,
- A Donato1,
- G Corda1,
- F Li4,
- M Vedadi4,5,
- AH Németh6,7,
- PE Brennan2,3 and
- R Wade-Martins*,1
- 1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, United Kingdom
- 2Structural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, United Kingdom
- 3Alzheimer’s Research UK Oxford Drug Discovery Institute, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom
- 4Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada
- 5Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada
- 6Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom
- 7Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, OX37DU
- ↵*To whom correspondence should be addressed Email: richard.wade-martins{at}dpag.ox.ac.uk Tel: +44 1865282837